Bioregenx (BRGX) Long-Term Debt Issuances (2024 - 2025)
Bioregenx's Long-Term Debt Issuances history spans 3 years, with the latest figure at -$147507.0 for Q4 2025.
- Quarterly results put Long-Term Debt Issuances at -$147507.0 for Q4 2025, down 137.33% from a year ago — trailing twelve months through Sep 2025 was $542615.0 (up 412.23% YoY), and the annual figure for FY2024 was $427187.0, up 478.43%.
- Long-Term Debt Issuances for Q4 2025 was -$147507.0 at Bioregenx, down from $117507.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $395108.0 in Q4 2024 to a low of -$367921.0 in Q3 2024.
- The 3-year median for Long-Term Debt Issuances is $86926.5 (2023), against an average of $62630.0.
- The sharpest move saw Long-Term Debt Issuances soared 434.99% in 2024, then tumbled 137.33% in 2025.
- Year by year, Long-Term Debt Issuances stood at $73853.0 in 2023, then soared by 434.99% to $395108.0 in 2024, then tumbled by 137.33% to -$147507.0 in 2025.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at -$147507.0, $117507.0, and $30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.